News

Regular use of antibiotics to treat persistent infections is linked with hypersensitivity reactions in individuals with cystic fibrosis (CF), a new study has found. Specifically, “the risk is highly associated with the number of cumulative exposures to antibiotics and increasing age,” the researchers wrote. And intravenous, or into-the-vein, administration…

Using a machine learning approach based on genetic data, a trio of scientists at Scripps Research identified a region of the CFTR protein that is vital for its proper function, but is barely affected by existing cystic fibrosis (CF) treatments. Researchers described their findings in the study “…

The Lung Transplant Foundation is hosting a meeting with the U.S. Food and Drug Administration (FDA) with the intent of educating the agency and public about the challenges of living with bronchiolitis obliterans syndrome (BOS), a severe complication of lung transplants. “This is the first time that regulators and policymakers…

Treatment with the antibiotic azithromycin did not prevent the development of lung damage in infants with cystic fibrosis (CF), but was safe and lowered inflammation, hospital stays and antibiotic usage, according to data from a Phase 3 clinical trial. “Azithromycin treatment from diagnosis of cystic fibrosis after newborn…

When an initial antibiotic failed to improve lung function with a pulmonary exacerbation, switching antibiotics did not lead to greater gains among adults or children with cystic fibrosis (CF), a study found. “It appears clear that regardless of antibiotic choice, there is a subset of patients who will be slow…

Adults with cystic fibrosis (CF) who live with recurrent nose and sinus inflammation — called chronic rhinosinusitis, or CRS — have a poor health-related quality of life (HRQoL), and need improved diagnosis and treatment, a large Canadian study concluded. These findings were especially true for patients who experienced severe…

Kaftrio (elexacaftor, tezacaftor, and ivacaftor) is safe and effective in children with cystic fibrosis (CF) ages 6 to 11 with specific genetic mutations and advanced lung disease, according to a small study. Findings showed the therapy improved children’s lung function and reduced the need for antibiotics. The children’s…

Wheezing — noisy breathing with a whistling sound — occurs in nearly three of every four preschool-aged children with cystic fibrosis (CF), and its presence at age 6 is linked to worse lung function, a French study has found. Researchers also observed that the majority of older children and…

Lupin has received tentative approval from the U.S. Food and Drug Administration (FDA) to market ivacaftor tablets, a generic version of the cystic fibrosis (CF) therapy Kalydeco. The company’s request came in the form of an abbreviated new drug application (ANDA), containing data submitted for review and approval…

A pediatric gastroenterologist in Missouri has been awarded a $50,000 grant to open a study into the potential of an FDA-approved nonsurgical device, called IB-Stim, as a way of easing abdominal pain in children with cystic fibrosis (CF). The grant, by the Institute of…